Delivery Order SPE2DR25D7064-SPE2DR26F2MYM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,336.32 to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-tablet supply) on July 31, 2025, with ultimate completion by August 1, 2025. This is a firm fixed price, non-set-aside delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.66 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of July 18, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, is executing this order as a child contract under its broader...
- The Defense Logistics Agency awarded a $1,155.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablets (21-count packages) on December 30, 2025, with completion targeted for December 31, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $24,256.99 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21-count packages) on December 8, 2025, with an ultimate completion date of December 9, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $12,314.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21 count packages) on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside competitive award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,500.57 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance taking place at its corporate office...
- The Defense Logistics Agency has awarded a delivery order valued at $63,466.34 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages). This firm fixed-price, competitively awarded contract (with no set-aside designation) is effective through November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,155.38 on December 10, 2025, for Loestrin 21 1-20 Tablet (21-count units). This non-competitive delivery order, with a firm fixed price structure, represents a routine pharmaceutical procurement through the company's existing contract vehicle. The place of performance is listed as AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of December 11, 2025. This...
- SPE2DR25D7064Indefinite Delivery Contract
- SPE2DR25D7064-SPE2DR26F2MYMDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $1,155.38 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 31, 2025. The award date of December 30, 2025 indicates this is a final delivery order placed under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The IDC serves as a global pharmaceutical support mechanism enabling the company to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a child contract under this prime indefinite delivery vehicle, this order exemplifies the company's role as a preferred pharmaceutical vendor for the Defense Health Agency and other federal healthcare systems, delivering essential medications across multiple therapeutic domains to support defense health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/29/25 |